MAPT and Alzheimer disease: The level of CSF sTREM2 was positively correlated with the core CSF biomarkers Aβ1–42, Aβ1–40, T-tau and P-tau on the entire data set and in preclinical AD, which further suggests an early involvement of reactive microgliosis.